申请人:Takeda Chemical Industries, Ltd.
公开号:US04349547A1
公开(公告)日:1982-09-14
2-(.alpha.-hydroxy-m-trifluoromethylbenzyl)azetidine and its physiologically acceptable acid addition salts have antiobesity action as well as suppressive action against oversecretion of insulin.
2-(α-羟基-m-三氟甲基苯基)氮杂环丙烷及其生理上可接受的酸盐具有抗肥胖作用,同时还具有抑制胰岛素过度分泌的作用。